| Financial Year |
March 31 2023 |
| Monetary Funds |
4,036,738,134.17 |
| Held-for-trading Financial Assets |
11,600,000.00 |
| Notes Receivable |
306,035,412.98 |
| Accounts Receivable |
2,212,703,764.03 |
| Advances to Suppliers |
250,424,008.99 |
| Other Receivables |
901,823,827.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,435,601,663.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
273,123,770.86 |
| Total Current Assets |
11,612,923,963.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
316,478,379.71 |
| Investment Properties |
23,406,356.86 |
| Fixed Assetes |
3,666,492,033.61 |
| Under-construction Projects |
338,599,539.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
859,265,339.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
208,953,496.02 |
| Other Non-Current Assets |
718,474,026.20 |
| Sub-Total of Non-Current Assets |
6,328,435,854.91 |
| Total Assets |
17,941,359,818.31 |
| Short-Term Loans |
5,775,063,844.80 |
| Trading Financial liabilities |
-- |
| Notes Payable |
13,589,319.67 |
| Accounts Payable |
754,344,009.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
34,905,164.13 |
| Taxes Payable |
132,582,499.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
123,560,090.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
950,726,069.34 |
| Other Current Liabilities |
65,025,223.89 |
| Sub-Total of Current Liabilities |
8,361,608,226.20 |
| Long-term Loans |
894,438,548.62 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
150,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
101,284,786.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,386,739,881.56 |
| Total Liabilities |
9,748,348,107.76 |
| Paid-In Capital(Or Share Stock) |
4,003,598,603.00 |
| Capital Surplus |
1,527,164,906.86 |
| Surplus Reserve |
179,882,160.03 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,472,475,620.52 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,193,011,710.55 |
| Owner's Equity（Stockholder's Equity） |
8,193,011,710.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,941,359,818.31 |
